Quick Answer
LianBio reported Total Assets of $319.96 million for fiscal year 2022.
LianBio Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2022 | $319.96M | -25.0% |
| 2021 | $426.34M | +52.7% |
| 2020 | $279.29M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $262.90M | -25.3% | -5.7% |
| June 30, 2023 | $278.80M | -25.0% | -7.9% |
| March 31, 2023 | $302.58M | -26.8% | -5.4% |
| December 31, 2022 | $319.96M | -25.0% | -9.1% |
| September 30, 2022 | $351.84M | — | -5.4% |
| June 30, 2022 | $371.81M | — | -10.1% |
| March 31, 2022 | $413.48M | — | -3.0% |
| December 31, 2021 | $426.34M | — | — |
- LianBio showed a decrease of -25.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2022 period, LianBio’s total assets has grown by 14.6% (from $279.29 million to $319.96 million).
- The most recent figure is from LianBio’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 28, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: